BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26038711)

  • 1. Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa.
    Bestawros M; Chidumayo T; Blevins M; Canipe A; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
    J AIDS Clin Res; 2015 Mar; 6(3):. PubMed ID: 26038711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
    Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
    BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Endothelial Dysfunction and Antiretroviral Therapy in Early HIV Infection.
    Bush KNV; Teel JL; Watts JA; Gore RS; Alvarado G; Harper NL; Okulicz JF
    JAMA Netw Open; 2019 Oct; 2(10):e1913615. PubMed ID: 31626317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of the interaction between short-term, metronome-paced heart rate variability, and inflammation: results from the population-based CARLA cohort study.
    Medenwald D; Swenne CA; Loppnow H; Kors JA; Pietzner D; Tiller D; Thiery J; Nuding S; Greiser KH; Haerting J; Werdan K; Kluttig A
    Europace; 2017 Jan; 19(1):110-118. PubMed ID: 27221352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
    Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
    Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy.
    Woodd SL; Kelly P; Koethe JR; Praygod G; Rehman AM; Chisenga M; Siame J; Heimburger DC; Friis H; Filteau S
    BMC Infect Dis; 2016 Oct; 16(1):562. PubMed ID: 27733134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
    Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
    J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Low Dose of Fish Oil on Inflammatory Markers of Brazilian HIV-Infected Adults on Antiretroviral Therapy: A Randomized, Parallel, Placebo-Controlled Trial.
    Oliveira JM; Rondó PH; Lima LR; Fortuna ES; Yudkin JS
    Nutrients; 2015 Aug; 7(8):6520-8. PubMed ID: 26251920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
    Thanou A; Stavrakis S; Dyer JW; Munroe ME; James JA; Merrill JT
    Arthritis Res Ther; 2016 Sep; 18(1):197. PubMed ID: 27590046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
    Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
    J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.
    Lawn SD; Myer L; Bekker LG; Wood R
    BMC Infect Dis; 2006 Mar; 6():59. PubMed ID: 16551345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients.
    Barnes JN; Nualnim N; Sugawara J; Sommerlad SM; Renzi CP; Tanaka H
    Am J Hypertens; 2011 Nov; 24(11):1194-200. PubMed ID: 21833040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
    Guzmán-Fulgencio M; Medrano J; Rallón N; Echeverria-Urabayen A; Miguel Benito J; Restrepo C; García-Álvarez M; Vispo E; San Roman J; Sánchez-Piedra C; Soriano V; Resino S
    J Infect; 2011 Nov; 63(5):382-90. PubMed ID: 21855573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.
    Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; Gérard L; May T; Simon A; Vigouroux C; Goujard C;
    PLoS One; 2015; 10(12):e0144317. PubMed ID: 26636578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors.
    Van Rossum AM; Gaakeer MI; Verweel S; Hartwig NG; Wolfs TF; Geelen SP; Lamberts SW; de Groot R
    Pediatr Infect Dis J; 2003 Jan; 22(1):70-6. PubMed ID: 12544412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
    Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C
    PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.